The board of directors of Extrawell Pharmaceutical Holdings Limited announced that Mr. Xue Jing Lun, an independent non-executive Director, and a member of each of the audit committee, remuneration committee and nomination committee of the Company, passed away on 4 December 2022 due to illness. Following the passing away of Mr. Xue, the Board comprises six Directors, including four executive Directors and two independent non-executive Directors. The Company currently does not meet (i) the minimum number of independent non-executive directors required under Rule 3.10(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited; and (ii) the minimum number of members in the audit committee required under Rule 3.21 of the Listing Rules.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.037 HKD | -2.63% | -9.76% | +8.82% |
2023 | Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses | MT |
2023 | Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.82% | 11.61M | |
+42.26% | 748B | |
+33.79% | 598B | |
-5.61% | 356B | |
+18.35% | 325B | |
+4.95% | 283B | |
+17.60% | 245B | |
+9.25% | 211B | |
-4.17% | 209B | |
+3.07% | 166B |
- Stock Market
- Equities
- 858 Stock
- News Extrawell Pharmaceutical Holdings Limited
- Extrawell Pharmaceutical Holdings Limited Announces Demise of Mr. Xue Jing Lun, Independent Non-Executive Director, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee